RYAN KENNEDY
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism BRISTOL, TN NPI 1295053759
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism TN Medtronic, Inc. All categories
General Payments — all program years on this page
$37,343.58
- Category: General Payments
- Program years: PY2018–2024
- Record count: 832
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $3,111.05 across 83 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,611.05 | 82 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,500.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $1,777.19 | 10 |
| Lilly USA, LLC | $276.82 | 14 |
| Novo Nordisk AS | $273.18 | 19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $90.62 | 5 |
| Bayer HealthCare Pharmaceuticals Inc. | $86.90 | 5 |
| Insulet Corporation | $74.02 | 4 |
| Xeris Pharmaceuticals, Inc. | $63.40 | 3 |
| Amgen Inc. | $56.61 | 2 |
| Radius Health, Inc. | $52.03 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $46.25 | 3 |
| DEXCOM, INC. | $43.89 | 2 |
| Abbott Laboratories | $33.40 | 2 |
| SANOFI-AVENTIS U.S. LLC | $32.70 | 2 |
| Tandem Diabetes Care, Inc. | $31.92 | 1 |
| Averitas Pharma Inc. | $26.61 | 1 |
| Corcept Therapeutics | $23.47 | 1 |
| BETA BIONICS, INC. | $21.39 | 1 |
| Neurocrine BioSciences, Inc. | $20.44 | 1 |
| PFIZER INC. | $19.84 | 1 |
| Alexion Pharmaceuticals, Inc. | $19.09 | 1 |
| IBSA Pharma Inc. | $14.17 | 1 |
| Antares Pharma, Inc. | $13.86 | 1 |
| Esperion Therapeutics, Inc. | $13.25 | 1 |
By program year
Records — PY2024 (83)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.